Effect of Berberine on the expression of lipid metabolism-associated gene PPARα and CPTIA

Chinese Pharmacological Bulletin

Volumn 24, Issue 11, 2008, Pages 1461-1464

  Shi, Ling Yun ^a,b   Tian, Mi ^a,b   Chang, Wei ^a,b   Yuan, Ye ^a,b   Zhou, Qi Xin ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b Chongqing Key Laboratory of Biochemistry and Molecular Pharmacology   (China)

Author keywords

Ber; CPT I A; HepG2; Lipid metabolism; PPAR

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; BERBERINE; CARNITINE PALMITOYLTRANSFERASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST;

ARTICLE; CELL STRAIN HEPG2; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; HUMAN; HUMAN CELL; LIPID METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 60749103999     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Kong W J, Wei J, Alidi P, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins[J]. Nat Med,2004,10(12):1344-51.
2. Wang C B, Lu F E, Leng S H, et al. Effects of berberine on the activity of glucokinase and the gene expression in cultured hepG2 cells[J]. Chin Pharmacol Bull,2007,23(9):1145-7.
3. Ko B S, Choi S B, Park S K, et al. Insulin sensitizing and insulino-tropic action of berberine from Cortidis rhizoma[J]. Biol Pharmacol Bull,2005,28(8):1431-7.
4. Yin J, Gao Z, Liu D, et al. Berberine improves glucose metabolism through induction of glycolysis [J]. Am J Physiol Endocrinol Metab,2008, 294:E148-6.
5. Zhang T, Yang G Z, Yuan Y, et al. Construction of high efficient eukaryotic expression vector carrying human PPARα gene and its significance[J]. Chin Pharmacol Bull,2007,23(3):413-7.
6. Duez H, Lefebvre B, Poulain P, et al. Regulation of human apoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferators-activated receptor alpha modulation[J]. Arterioscler Thromb Vasc Biol,2005,25(3):585-91.
7. Sohultze A F, Alborn W E, Newton R K, Konrad R J. Administration of a PPARα agonist increases serum apolipoprotein A-V levels and the apolipoprotein A-V/apolipoprotein C-III ratio[J]. J Lipid Res,2005, 46(8):1591-5.
8. Mandard S, Muller M, Kersten S. Peroxisome proliferator activated receptor α target genes[J]. Cell Mol Life Sci,2004,61(4):393-416.
9. Staels B, Dallongeville J, Auwerx J, et al. Mechanism of action of fibrates on lipid and lipoprotein[J]. Metabol Circ,1998,98(19): 2088-93.
10. He M K, Lu F E, Wang K F, et al. Effect and mechanisms of herberine on hyperlipidemic and insulin resistant rats[J]. Chin Hosp Pharm J,2004, 24(7):389-91.
11. Brusq J M, Amcellin N, Crondin P, et al. Inhibition of lipid synthesis through activation of AMP-kinase: An additional mechanism for the hypolipidemic effects of Berberine[J]. J Lipid Res,2006,47 (6):1281-8.
12. Mascaró C, Acosta E, Ortiz J A. Control of Human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor[J]. J Biol Chem,1998,273(15): 8560-3.
13. Brandt J M, Djouadi F, Kelly D P. Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha [J]. J Biol Chem,1998, 273(37):23786-92.